Thank you for registering! We look forward to welcoming you to Boston in June!
You will shortly be receiving an automatic email confirming your online registration and within the next 24 hours, you will receive your invoice and/or payment confirmation.
If you have any questions about your registration, please contact
Telephone: +44 (0)20 3141 8700 or +1 (212) 537 5898
Email: [email protected]
We look forward to welcoming you to the conference.
Want to Share That You Are Attending?
We would love for you to share that you are you attending the 7th Annual Allogeneic Cell Therapies Summit. Please see your banner below.
Want to make it even easier? Here is some text to go with it:
''I am attending the 7th Annual Allogeneic Cell Therapies Summit this June. I am looking forward to hearing industry experts share their recent advancements and unite for strategy-led discussions on how to further advance the allogeneic cell therapy space. Join me! https://ter.li/3vxx0s''
Looking for Somewhere to Stay?
We are pleased to let you know that we have a dedicated room block at the conference venue, Revere Hotel Boston Common, with a nightly room rate of $299.00 from Monday, June 9 to Thursday, June 11! Please click here to secure your booking.
Please note that reservations must be made by Monday, May 19, but rooms are likely to sell-out prior to this so we urge you to book your accommodation at your earliest convenience.
If you have any questions, please reach out to the Event Manager, Chlöe.
Explore Related Products
Cell Therapy
Delivering Safer, More Effective & Globally Accessible Cell Therapies to Patients at Scale
Conferences
Our Cell Therapy conferences aim to supercharge durable, safe, and cost-effective cell therapies for patients. We focus on helping overcome the discovery, translational, clinical, and commercial hurdles to realize cell therapies for patients at scale.
Data
Beacon's cell therapy database covers trial and drug records for preclinical, active, approved, and discontinued CAR (chimeric antigen receptor) modified therapies, TCR (T-Cell Receptor) therapies, natural killer cells, tumor-infiltrating lymphocytes cytokine-induced killer cells, dendritic cells, and macrophages.
Research
A trusted provider of market intelligence for anyone looking to understand the complexities of cell therapy research and development.